When the Biomedical Industry Can’t Prioritize Diseases, Private Money Can Save Lives
Release Date:
09/19/2014
... Nearly two million people in the U.S. suffer from type 1 diabetes (T1D), and millions more are affected worldwide. ... a new device or drug to market—which can easily reach $ 1 billion—a relatively small...
